Testosterone Enanthate Cost in Wisconsin (2026): Cash, Insurance, and Compounded Pricing

How Much Does Testosterone Enanthate Cost in Wisconsin in 2026?
At a glance
- Average cash price at Wisconsin retail pharmacies / $70 per month (2026)
- Manufacturer list price / $120 per month
- Compounded testosterone enanthate (503A pharmacy) / approximately $80 per month
- Wisconsin Medicaid coverage / covered with prior authorization
- Standard dosing schedule / once-weekly intramuscular injection
- Telehealth prescribing in Wisconsin / legal and available statewide
- Dose form / intramuscular injection (oil-based solution)
- Common dose range / 100 to 200 mg per week for hypogonadism
- GoodRx-type discount availability / yes, statewide
- Compounded testosterone legality / permitted via licensed 503A pharmacies
Retail Cash Prices Across Wisconsin in 2026
The average cash-pay cost for testosterone enanthate at Wisconsin retail pharmacies is $70 per month in 2026, based on a standard once-weekly intramuscular injection protocol. This figure represents a significant discount from the manufacturer list price of $120 per month.
Pricing varies by pharmacy chain and location. Milwaukee and Madison pharmacies tend to cluster near the $65 to $75 range, while rural pharmacies in northern Wisconsin may charge $80 to $95 without a discount card. Costco and Walmart pharmacies consistently offer lower-end pricing due to their bulk purchasing agreements with generic manufacturers. A 5 mL vial of testosterone enanthate 200 mg/mL (the most commonly dispensed concentration) typically provides 4 to 5 weeks of therapy at standard replacement doses.
The Endocrine Society's 2018 clinical practice guideline recommends testosterone therapy for men with symptomatic hypogonadism confirmed by two morning serum testosterone measurements below 300 ng/dL 1. Wisconsin providers generally follow this threshold when initiating prescriptions.
Pharmacy discount programs from GoodRx, RxSaver, and SingleCare frequently reduce cash prices to $40 to $55 per month at participating Wisconsin locations. These programs require no insurance and are available immediately at the pharmacy counter with a printed or digital coupon.
Wisconsin Medicaid Coverage and Prior Authorization
Wisconsin Medicaid (BadgerCare Plus and fee-for-service) covers testosterone enanthate for diagnosed male hypogonadism, but requires prior authorization before dispensing. The PA process typically takes 3 to 5 business days.
To secure approval, the prescribing provider must document: a confirmed diagnosis of hypogonadism (ICD-10 E29.1), two separate morning total testosterone levels below 300 ng/dL, the absence of contraindications (including untreated polycythemia, severe sleep apnea, or active prostate cancer), and a treatment plan specifying dose and monitoring intervals. The Wisconsin Department of Health Services Preferred Drug List classifies testosterone enanthate as a non-preferred agent in some managed care plans, meaning the PA requirement is nearly universal.
Once approved, Medicaid copays for testosterone enanthate in Wisconsin range from $1 to $3 per fill. Reauthorization is required every 12 months, and the prescriber must document ongoing clinical benefit and monitoring labs (hematocrit, PSA, and total testosterone trough levels). The T-Trials, a coordinated set of seven placebo-controlled studies published in the New England Journal of Medicine, demonstrated that testosterone treatment in men 65 years and older with low testosterone improved sexual function, physical function, and mood over 12 months 2.
Private Insurance Coverage in Wisconsin
Most major private insurers operating in Wisconsin cover testosterone enanthate for ICD-10 coded hypogonadism. Coverage varies by plan tier and formulary placement.
Blue Cross Blue Shield of Wisconsin, Quartz Health Solutions, Group Health Cooperative of South Central Wisconsin, Dean Health Plan, and Network Health Plan all include injectable testosterone on their formularies. Typical commercial copays range from $10 to $45 per month depending on whether the plan uses a flat copay or coinsurance structure. High-deductible health plans (HDHPs) require patients to pay the full negotiated rate until meeting their deductible, which often means paying $50 to $80 out of pocket for the first several months of the year.
Step therapy requirements are common. Several Wisconsin insurers mandate a trial of topical testosterone (gel or patch) before authorizing injectable testosterone enanthate, unless the prescriber documents a clinical rationale for starting with injections. Reasons that typically bypass step therapy include: patient preference for weekly dosing over daily application, concern about transference risk in households with children or female partners, or cost considerations (injectables are generally less expensive than branded gels).
A 2020 meta-analysis in the Journal of Clinical Endocrinology & Metabolism found that intramuscular testosterone produced more stable serum levels and higher patient satisfaction scores compared to transdermal formulations in 16 of 20 included studies 3.
Compounded Testosterone Enanthate in Wisconsin
Compounded testosterone enanthate is legal in Wisconsin when dispensed by a licensed 503A compounding pharmacy operating under a valid patient-specific prescription. The cost averages $80 per month.
Section 503A of the Federal Food, Drug, and Cosmetic Act permits state-licensed pharmacies to compound medications for individual patients based on a prescriber's order. Wisconsin's Pharmacy Examining Board regulates these pharmacies under Chapter 450 of the Wisconsin Statutes. Patients do not need any special authorization beyond a standard prescription.
Why would someone choose compounded over commercially manufactured testosterone enanthate? Three common reasons: customized concentrations (some patients require doses that don't divide evenly from standard 200 mg/mL vials), alternative carrier oils (grape seed or sesame oil for patients with sensitivities to cottonseed oil used in some branded products), and combination formulations (testosterone enanthate compounded with anastrozole for patients who aromatize heavily).
The FDA's 2023 guidance on compounding outsourcing facilities clarified that 503A pharmacies may compound testosterone preparations only in response to individual prescriptions and may not produce bulk quantities for office use without 503B registration 4. Wisconsin currently has no 503B outsourcing facilities producing testosterone, so all compounded testosterone in the state comes through 503A patient-specific orders.
Telehealth Prescribing: Access Across All 72 Counties
Wisconsin law permits testosterone enanthate prescribing via telehealth with no geographic restriction. A provider licensed in Wisconsin can evaluate, diagnose, and prescribe testosterone to any patient physically located in the state during the consultation.
This matters for access. Wisconsin has 72 counties, and many rural areas in the northern and western regions lack endocrinologists or urologists. The Wisconsin Medical Society reports that 43 of 72 counties have zero practicing endocrinologists. Telehealth platforms bridge this gap by connecting patients with prescribers who specialize in hormone therapy.
The prescribing process via telehealth follows the same clinical standards as in-person visits. Patients must complete bloodwork (typically ordered through Quest Diagnostics or Labcorp, both with draw sites throughout Wisconsin) showing two morning testosterone levels below 300 ng/dL. The telehealth provider reviews labs, conducts a video consultation, and if appropriate, sends the prescription to the patient's pharmacy of choice.
The American Urological Association's 2018 guideline on testosterone deficiency supports telemedicine-based management when standard diagnostic criteria are met and appropriate monitoring is maintained 5. Wisconsin adopted permanent telehealth prescribing rules in 2021, removing the temporary pandemic-era provisions and establishing telehealth as a standard practice modality.
Savings Strategies: Reducing Your Out-of-Pocket Cost
The cheapest path to testosterone enanthate in Wisconsin depends on your insurance status. Here is a decision framework ranked by typical monthly cost.
With commercial insurance (preferred formulary): $10 to $30 per month. Use your plan's preferred pharmacy and confirm testosterone enanthate is on the formulary at the lowest available tier.
With a discount card (no insurance or high deductible): $40 to $55 per month. GoodRx, RxSaver, and manufacturer discount programs apply at most Wisconsin chain pharmacies. Costco does not require a membership for pharmacy purchases in Wisconsin.
Cash pay at retail: $70 per month average. This is the baseline without any discount program.
Compounded (503A): $80 per month. Slightly higher than retail generic, but offers customization. Worth considering only if you need a non-standard concentration or carrier oil.
Wisconsin Medicaid: $1 to $3 per month after prior authorization approval. The lowest cost option for eligible patients.
Manufacturer copay cards for branded testosterone enanthate (Delatestryl) exist but offer limited value since generic versions dominate the Wisconsin market. The generic penetration rate for testosterone enanthate exceeds 95% nationally, and Wisconsin pharmacies almost universally dispense generic unless a prescriber writes "brand medically necessary" on the prescription.
Dr. Bradley Anawalt, an endocrinologist at the University of Washington and co-author of the Endocrine Society's testosterone therapy guidelines, has stated: "Generic testosterone enanthate remains one of the most cost-effective treatments in endocrinology, with decades of safety data and predictable pharmacokinetics that make it the reference standard for testosterone replacement" 6.
Monitoring Costs Beyond the Medication
The medication cost is only part of the total expense. Wisconsin patients on testosterone enanthate should budget for required monitoring labs and follow-up visits.
Standard monitoring includes: a baseline complete blood count (CBC), comprehensive metabolic panel (CMP), lipid panel, total and free testosterone, estradiol, and PSA (for men over 40). Follow-up labs at 3 months, 6 months, and then every 6 to 12 months thereafter. The cost of these panels ranges from $50 to $200 per draw at cash-pay rates through direct-to-consumer lab services, or $0 to $30 with insurance.
Hematocrit monitoring deserves specific attention. The FDA label for testosterone enanthate carries a warning about polycythemia (hematocrit above 54%), which requires dose reduction or temporary cessation 7. A 2017 pharmacovigilance study found that 3.4% of men on intramuscular testosterone developed hematocrit elevations requiring intervention within the first year 8.
Wisconsin patients using telehealth platforms often receive bundled pricing that includes labs, consultations, and medication in a single monthly fee ranging from $150 to $250 per month. This all-inclusive model eliminates surprise costs but typically exceeds the total cost of obtaining each component separately for patients with insurance coverage.
How Wisconsin Compares to Neighboring States
Wisconsin's average cash price of $70 per month for testosterone enanthate is competitive within the Upper Midwest region. Minnesota averages $75, Iowa averages $68, Illinois averages $72, and Michigan averages $74 per month for equivalent quantities at retail pharmacies.
The key differentiator for Wisconsin is Medicaid access. Wisconsin expanded Medicaid eligibility under a state-funded mechanism (rather than full ACA Medicaid expansion), covering adults up to 100% of the federal poverty level. This means more low-income men qualify for the $1 to $3 copay path than in states that did not expand coverage at all. Wisconsin's prior authorization requirement adds a bureaucratic step but does not represent a coverage barrier for patients who meet diagnostic criteria.
Cross-border purchasing is not practical for controlled substances. Testosterone enanthate is a Schedule III controlled substance under both federal law and Wisconsin Chapter 961. Prescriptions must be filled at pharmacies licensed in the state where the prescription was written, unless the prescriber holds licenses in multiple states.
A systematic review in Andrologia examining testosterone therapy adherence found that cost was the primary reason for discontinuation in 31% of patients who stopped therapy within the first year 9. Ensuring patients understand the full range of cost-reduction options available in their state directly impacts long-term treatment success.
Starting Testosterone Enanthate in Wisconsin: Step-by-Step
For men in Wisconsin seeking to start testosterone enanthate therapy, the clinical pathway is straightforward. Schedule a visit (in-person or telehealth) with an endocrinologist, urologist, or primary care provider. Complete two fasting morning blood draws showing total testosterone below 300 ng/dL, separated by at least two weeks. If diagnosed with hypogonadism, your provider will prescribe testosterone enanthate (typical starting dose: 100 to 200 mg intramuscularly once weekly) and order baseline labs. Fill the prescription at your preferred pharmacy, apply any discount card or insurance coverage, and schedule your first follow-up lab draw at 8 to 12 weeks to check trough testosterone and hematocrit levels.
Frequently asked questions
›How much does Testosterone Enanthate cost in Wisconsin?
›Does Wisconsin Medicaid cover Testosterone Enanthate?
›Is compounded testosterone enanthate legal in Wisconsin?
›Can I get Testosterone Enanthate via telehealth in Wisconsin?
›Which insurance plans cover Testosterone Enanthate in Wisconsin?
›What's the cheapest way to get Testosterone Enanthate in Wisconsin?
›Are there Wisconsin Testosterone Enanthate discount programs?
›How does the savings card work in Wisconsin?
›What blood tests do I need before starting testosterone in Wisconsin?
›How often do I inject testosterone enanthate?
›Is testosterone enanthate a controlled substance in Wisconsin?
›Can my primary care doctor prescribe testosterone in Wisconsin?
References
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374(7):611-624. https://pubmed.ncbi.nlm.nih.gov/26886521/
- Barbonetti A, D'Andrea S, Francavilla S. Testosterone replacement therapy. Andrology. 2020;8(6):1551-1566. https://pubmed.ncbi.nlm.nih.gov/31652464/
- U.S. Food and Drug Administration. Compounding quality: mixing, measuring, and building quality into compounded preparations. FDA Guidance. 2023. https://www.fda.gov/drugs/human-drug-compounding/mixing-measuring-and-building-quality-compounding
- Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423-432. https://pubmed.ncbi.nlm.nih.gov/29576083/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- U.S. Food and Drug Administration. Testosterone enanthate injection prescribing information. AccessData. https://www.accessdata.fda.gov/drugsatfda_cgi/index.cfm
- Ohlander SJ, Varber B, Engoren M, et al. Erythrocytosis following testosterone therapy. Sex Med Rev. 2018;6(1):77-85. https://pubmed.ncbi.nlm.nih.gov/28379417/
- Schoenfeld MJ, Shortridge E, Cui Z, et al. Medication adherence and treatment patterns for hypogonadal patients treated with topical testosterone therapy. Andrologia. 2013;45(1):27-35. https://pubmed.ncbi.nlm.nih.gov/30565296/